AstraZeneca PLC Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 60.35 M | $3.95 B | -4.04% | 1.95% |
PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 41.02 M | $2.69 B | -2.29% | 1.32% |
CAPITAL INTERNATIONAL INVESTORS | 02/13/2025 | 37.51 M | $2.46 B | 1.86% | 1.21% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 37.04 M | $2.43 B | -0.56% | 1.19% |
FMR LLC | 02/13/2025 | 22.31 M | $1.46 B | -3.49% | 0.72% |
FRANKLIN RESOURCES INC | 02/12/2025 | 19.48 M | $1.28 B | 1.87% | 0.63% |
JENNISON ASSOCIATES LLC | 01/24/2025 | 15.43 M | $1.01 B | 3.12% | 0.50% |
SANDERS CAPITAL, LLC | 02/13/2025 | 15.19 M | $995.03 M | 1.42% | 0.49% |
FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 10.96 M | $718.09 M | 4.58% | 0.35% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 10.39 M | $680.66 M | -13.76% | 0.34% |
CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2025 | 8.11 M | $539.70 M | -10.83% | 0.26% |
NEUBERGER BERMAN GROUP LLC | 02/13/2025 | 5.69 M | $372.68 M | 8.70% | 0.18% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 5.32 M | $348.73 M | 13.58% | 0.17% |
JPMORGAN CHASE & CO | 02/12/2025 | 5.25 M | $343.82 M | -1.41% | 0.17% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 4.96 M | $324.85 M | -19.39% | 0.16% |
D. E. SHAW & CO., INC. | 02/14/2025 | 4.83 M | $316.22 M | 203.27% | 0.16% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 4.68 M | $306.44 M | 9.10% | 0.15% |
GQG PARTNERS LLC | 02/11/2025 | 4.38 M | $286.67 M | -20.09% | 0.14% |
HOLOCENE ADVISORS, LP | 02/14/2025 | 4.30 M | $281.76 M | 100.00% | 0.14% |
MARSHALL WACE, LLP | 02/13/2025 | 3.88 M | $254.02 M | 100.00% | 0.13% |
UBS GROUP AG | 02/14/2025 | 3.85 M | $252.28 M | 119.74% | 0.12% |
MANNING & NAPIER ADVISORS LLC | 01/23/2025 | 3.75 M | $245.41 M | 17.74% | 0.12% |
WCM INVESTMENT MANAGEMENT, LLC | 02/11/2025 | 3.73 M | $244.61 M | -5.28% | 0.12% |
BOSTON PARTNERS | 02/11/2025 | 3.71 M | $243.44 M | 9,985.63% | 0.12% |
FAYEZ SAROFIM & CO | 02/14/2025 | 3.64 M | $238.69 M | 5.78% | 0.12% |
ENVESTNET ASSET MANAGEMENT INC | 02/13/2025 | 3.55 M | $232.44 M | 0.85% | 0.11% |
CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 3.46 M | $226.97 M | -3.32% | 0.11% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 3.21 M | $210.36 M | -4.97% | 0.10% |
SOROS FUND MANAGEMENT LLC | 02/14/2025 | 3.16 M | $206.77 M | 18.96% | 0.10% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 3.10 M | $203.18 M | 65.09% | 0.10% |
ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 3.03 M | $198.36 M | 220.76% | 0.10% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.90 M | $189.87 M | 2,346.00% | 0.09% |
INVESCO LTD. | 02/13/2025 | 2.86 M | $187.31 M | -2.66% | 0.09% |
SWEDBANK AB | 01/22/2025 | 2.83 M | $185.51 M | 4.64% | 0.09% |
ROYAL BANK OF CANADA | 02/14/2025 | 2.43 M | $159.40 M | -2.34% | 0.08% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 2.41 M | $158.02 M | 100.00% | 0.08% |
NATIXIS ADVISORS, L.P. | 02/10/2025 | 2.06 M | $134.98 M | 5.07% | 0.07% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 2.04 M | $133.94 M | 22.44% | 0.07% |
EPOCH INVESTMENT PARTNERS, INC. | 02/13/2025 | 2.03 M | $132.80 M | 3.31% | 0.07% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.87 M | $122.20 M | 274.82% | 0.06% |
VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 1.76 M | $115.53 M | -65.02% | 0.06% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.74 M | $114.27 M | -2.25% | 0.06% |
SATURNA CAPITAL CORP | 02/07/2025 | 1.64 M | $107.28 M | -2.24% | 0.05% |
CRAWFORD INVESTMENT COUNSEL INC | 02/14/2025 | 1.61 M | $105.79 M | 5.11% | 0.05% |
ABRDN PLC | 01/24/2025 | 1.40 M | $91.83 M | 2.88% | 0.05% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 1.27 M | $83.27 M | -4.14% | 0.04% |
STIFEL FINANCIAL CORP | 02/13/2025 | 1.25 M | $81.86 M | -7.37% | 0.04% |
PHOENIX HOLDINGS LTD. | 02/13/2025 | 1.23 M | $80.87 M | 1,624.64% | 0.04% |
STATE STREET CORP | 02/14/2025 | 1.20 M | $78.61 M | -33.99% | 0.04% |
PARNASSUS INVESTMENTS, LLC | 02/10/2025 | 1.18 M | $77.25 M | 15,819.77% | 0.04% |
AstraZeneca PLC institutional Ownership - FAQ's
During the previous two years, 1628 institutional investors and hedge funds held shares of AstraZeneca PLC. The most heavily invested institutionals were:
PRICE T ROWE ASSOCIATES INC /MD/: 60.35 M
PRIMECAP MANAGEMENT CO/CA/: 41.02 M
Capital International Investors: 37.51 M
WELLINGTON MANAGEMENT GROUP LLP: 37.04 M
FMR LLC: 22.31 M
FRANKLIN RESOURCES INC: 19.48 M
16.55% of AstraZeneca PLC stock is owned by institutional investors.
Institutional investors have bought a total of 550.75 M shares in the last 24 months. This purchase volume represents approximately $36.81 B in transactions.